Clinical Trial Update: Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing safety and tolerability of frovatriptan for preventing menstrually associated migraine (MAM) headaches.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Migraine | Phase 3 | Status: COMPLETED